Skip to main content
Equibles

Nantahala Capital Management, LLC

Position in ADCT — ADC Therapeutics SA

CIK 1472322 New Canaan, CT
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$13,189,016
-$7,801,357 QoQ
Shares Held
12,326,184
+120.2% QoQ
Ownership
9.65%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#1
of 113 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $169,874,929 across 9 Drug Manufacturers - Specialty & Generic names. ADCT ranks #5 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ETON
Eton Pharmaceuticals, Inc.
 1,175,951 $42,569,426
2 AMRX
Amneal Pharmaceuticals, Inc.
 2,268,751 $39,272,079
3 EOLS
Evolus, Inc.
 5,602,021 $38,878,025
4 BCRX
Biocryst Pharmaceuticals Inc
 1,901,160 $19,011,600
5 ADCT
ADC Therapeutics SA
This page 		12,326,184 $13,189,016
6 AMLX
Amylyx Pharmaceuticals, Inc.
 486,684 $8,740,844
7 TLPH
Talphera, Inc.
 3,492,519 $3,597,294
8 AYTU
Aytu Biopharma, Inc
 1,086,812 $2,336,645

All Filings in ADCT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,189,016 12,326,184
2026-03-31 $20,990,373 5,597,433
2025-12-31 $19,328,278 5,475,433
2025-09-30 $9,065,156 2,266,289
2025-06-30 $6,073,654 2,266,289
2023-09-30 $230,674 257,162
2023-06-30 $1,806,000 840,000
2023-03-31 $1,638,000 840,000
2022-12-31 $934,233 243,290